A Comprehensive Board Review in Hematology and Medical Oncology

1. Apply knowledge gained to prepare for the hematology and medical oncology subspecialty and recertification examinations in hematology and medical oncology.
2. Utilize current standards of care for patients with cancer, blood disorders and malignancies.
3. Demonstrate proficiency of knowledge in hematology and medical oncology.
4. Incorporate recent advances in management of hematologic and oncologic patients.

A Virtual Live Streaming Course

The Comprehensive Board Review in Hematology and Medical Oncology will be virtual. This program will be presented only as a live streaming course.

PLANNING COMMITTEE

MD Anderson Cancer Center
Sharon Giordano, MD, MPH, Co-Director
Tapan Kadia, MD, Co-Director
Shreyaskumar Patel, MD
Alessandra Ferrajoli, MD
Nishin Bhadka, MD
Felisha Estelle

Baylor College of Medicine
Martha Mims, MD, PhD, Co-Director

• The Full Conference and Oncology Session will begin at 7:30 am on Monday, August 19, 2024. The Oncology Session will adjourn at 5:10 pm on Wednesday, August 21, 2024. The full conference will adjourn at 4:30 pm on Saturday, August 24, 2024.

• The Hematology Session will begin at 7:30 am on Thursday, August 22, 2024 and adjourn at 4:30 pm on Saturday, August 24, 2024.

Advanced registration is encouraged.  Please see the registration fees below.

*NOTE: The conference registration fee includes the tuition, access to course virtual platform with PDFs of the slides and Canvas - online web-based system with recorded videos.

The deadline for advanced registration is Monday, July 22, 2024.

We accept the following forms of payment:

• Credit Cards (MasterCard, VISA, and American Express)
• Check (payable through U.S. banks only)
• Mail to: Continuing Professional Education – Unit 1781, The University of Texas MD Anderson Cancer Center, P.O. Box 301407, Houston, TX 77230-1407

Make check payable to:  The University of Texas MD Anderson Cancer Center

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.

REFUND/CANCELLATION POLICY

The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before Monday, August 5, 2024.  No refunds will be granted after that date.  The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.  For additional information, contact Continuing Professional Education at 713-792-2223 or toll free at 866-849-5866.

Continuing Professional Education reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.

In case of activity cancellation, the liability of Continuing Professional Education is limited to the registration fee.  Continuing Professional Education will refund the full registration fee.

Continuing Professional Education reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

Please let us know what specific topics, issues, or questions you wish to see addressed or emphasized in this activity by emailing Continuing Professional Education at [email protected]. All responses will be forwarded to the Program Directors for consideration.

EVALUATION
An online course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

SPECIAL ASSISTANCE
Contact Felisha Estelle in Continuing Professional Education at 713-745-0083 or 1-866-531-MOBR (6627) if you have any ADA accommodation needs.

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

American Board of Internal Medicine (ABIM)
Successful completion of this CE activity, which includes participation in the evaluation component, enables the participant to earn up to 50.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CE credits claimed for the activity. It is the CE activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

In order to receive MOC points, you must pass the post-test with a score of 70% or higher.

Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf. 

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Sharon H. Giordano, MD, FASCO
Professor
The University of Texas MD Anderson Cancer Center

Co-Director, Faculty

Nothing to disclose

Tapan Kadia, MD
Professor
The University of Texas MD Anderson Cancer Center

Co-Director, Faculty

Grant or research support-Bristol-Myers Squibb Company|Honoraria-DAVA Oncology|Speakers Bureau-CURE|Honoraria-DrenBio|Grant or research support-Celgene Corporation|Grant or research support-BMS|Speakers Bureau-Biologix|Grant or research support-Janssen Biotech, Inc.|Grant or research support-Incyte Corporation|Grant or research support-Astex|Grant or research support-Abcuro|Grant or research support-Pfizer Inc.|Speakers Bureau-Hikma Pharmaceuticals|Consulting Fee-Genzyme Corporation|Grant or research support-Glycomimetics|Grant or research support-AbbVie Inc.|Grant or research support-Amgen Inc.|Grant or research support-Genentech, Inc.|Grant or research support-Ascentage|Grant or research support-Cellenkos (Relationship has ended)|Grant or research support-AstraZeneca US|Grant or research support-Astellas Scientific and Medical Affairs, Inc.|Paid consultant-AbbVie Inc.|Paid consultant-Genentech, Inc.|Grant or research support-Genfleet|Grant or research support-Sellas, Inc|Grant or research support-Delta Fly Pharma|Grant or research support-Jazz Pharmaceuticals|Paid consultant-Jazz Pharmaceuticals|Paid consultant-Novartis Pharmaceuticals Corporation|Paid consultant-Daiichi Sankyo, Inc.|Paid consultant-Agios Pharmaceuticals Inc.|Consulting Fee-PinotBio|Consulting Fee-Sanofi US|Paid consultant-Pfizer Inc.|Grant or research support-Regeneron Pharmaceuticals, Inc.|Consulting Fee-Servier Pharmaceuticals

Martha Mims, MD, PhD
Professor and Section Chief, Hematology/Oncology
Baylor College of Medicine

Co-Director, Faculty

Stocks or stock options, excluding diversified mutual funds-Amgen Inc.|Stocks or stock options, excluding diversified mutual funds-Biogen Inc.|Grant or research support-Janssen Biotech, Inc.|Grant or research support-Celgene Corporation|Grant or research support-Incyte Corporation|Grant or research support-inovio|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Board of Pensions of the Presbyterian church

Rodabe N. Amaria, MD
Associate Professor, Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty

Grant or research support-Novartis Pharmaceuticals Corporation (Relationship has ended)|Grant or research support-Erasca|Consulting Fee-Obsidian |Grant or research support-Merck Sharp & Dohme Corp. (any division) (Relationship has ended)|Grant or research support-Bristol-Myers Squibb Company (Relationship has ended)|Grant or research support-Iovance (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis Pharmaceuticals Corporation (Relationship has ended)|Grant or research support-Obsidian|Grant or research support-OnKure|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol-Myers Squibb Company (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-TIL Working Group|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Nektar (Relationship has ended)

Kenneth Bauer, MD, Physician
Professor
Beth Israel Deaconess Medical Center

Faculty

Nothing to disclose

Nancy Berliner, MD
Chief, Division of Hematology
Brigham and Women's Hospital

Faculty

Nothing to disclose

Abenaa Brewster, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Bradley Carthon, MD, PhD, MD, PhD
Associate Professor
Emory Healthcare

Faculty

Advisor-Gilead Sciences, Inc.|Grant or research support-AstraZeneca US|Advisor-Eisai, Inc. (Relationship has ended)

Carla Casulo, MD
University of Rochester

Faculty

Honoraria- Mashup Media (Relationship has ended)|Consulting Fee- Mashup Media (Relationship has ended)|Consulting Fee-Bristol-Myers Squibb Company|Honoraria-Bristol-Myers Squibb Company|Consulting Fee-AbbVie Inc.|Honoraria-AbbVie Inc.|Consulting Fee-Genentech, Inc.|Honoraria-Genentech, Inc.|Grant or research support-Genmab|Grant or research support-Gilead Sciences, Inc.|Grant or research support-Genentech, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-FL Cures Foundation|Membership on Advisory Committees or Review Panels, Board Membership, etc.-American Society of Hematology

Mariana C. Chavez MacGregor , MD, MSC, Associate Profesor
Associate Professor
The University of Texas MD Anderson Cancer Center

Faculty

Grant or research support-Novartis Pharmaceuticals Corporation (Relationship has ended)|Consulting Fee-Merck Research Laboratories and the Office of the Chief Medical Officer Grants (Relationship has ended)|Grant or research support-Lilly USA, LLC|Consulting Fee-Daiichi Sankyo, Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Pfizer Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca US|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genentech, Inc.|Advisor-Genomic Health, Inc. (Relationship has ended)

Jorge Cortes, MD
Director
Georgia Cancer Center at Augusta University

Faculty

Advisor-Pfizer Inc.|Advisor-Novartis Pharmaceuticals Corporation|Grant or research support-Novartis Pharmaceuticals Corporation|Advisor-Sun Pharma|Grant or research support-Sun Pharma|Advisor-Takeda|Advisor-BioPath Holdings|Grant or research support-AbbVie Inc.|Grant or research support-Ascentage|Advisor-Tern Pharma

Courtney D. Dinardo, MD
Associate Professor
The University of Texas MD Anderson Cancer Center

Faculty

Honoraria-AbbVie Inc.|Honoraria-Rigel|Honoraria-Daiichi Sankyo, Inc.|Honoraria-Gilead Sciences, Inc. (Relationship has ended)|Honoraria-Genentech, Inc.|Honoraria-Astellas Scientific and Medical Affairs, Inc. (Relationship has ended)|Honoraria-Bristol-Myers Squibb Company|Honoraria-GlaxoSmithKline|Honoraria-Jazz Pharmaceuticals|Honoraria-Novartis Pharmaceuticals Corporation (Relationship has ended)|Honoraria-Servier Pharmaceuticals|Honoraria-Immunogen (Relationship has ended)|Consulting Fee-Schrodinger|Advisor-Ellipses

Megan Dupuis , MD, PhD
Assistant Professor
Vanderbilt University Medical Center

Faculty

Nothing to disclose

Ramez Eskander, MD
Professor of Gynecologic Oncology
UC San Diego Moores Cancer Center

Faculty

Consulting Fee-AstraZeneca US|Advisor-Eisai, Inc.|Advisor-Immunogen (Relationship has ended)|Consulting Fee-PMV Pharmaceuticals (Relationship has ended)|Advisor-GlaxoSmithKline|Advisor-GOG Foundation|Advisor-Daiichi Sankyo, Inc. (Relationship has ended)|Advisor-AbbVie Inc.|Advisor-Clovis Oncology (Relationship has ended)|Advisor-CARIS Life Sciences (Relationship has ended)|Consulting Fee-Natera (Relationship has ended)|Advisor-Regeneron Pharmaceuticals, Inc. (Relationship has ended)

Christopher R. Flowers, MD, FASCO
Chair, Lymphoma/Myeloma, Division Head Ad Interim, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center

Faculty

Consulting Fee-Beigene|Consulting Fee-BioAscend (Relationship has ended)|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Curio Sciences (Relationship has ended)|Consulting Fee-Denovo Biopharma |Consulting Fee-Epizyme, Inc.|Consulting Fee-Genentech, Inc.|Consulting Fee-Foresight Diagnostics|Ownership-Foresight Diagnostics|Stocks or stock options, excluding diversified mutual funds-Foresight Diagnostics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Foresight Diagnostics|Consulting Fee-Genmab (Relationship has ended)|Consulting Fee-MorphoSys AG |Consulting Fee-Janssen Biotech, Inc. (Relationship has ended)|Consulting Fee-Seattle Genetics, Inc. (Relationship has ended)

Ravin J. Garg, MD
Medical Doctor
Maryland Oncology Hematology/US Oncology and Assistant Professor of Oncology/Johns Hopkins Hospital

Faculty

Nothing to disclose

Carl Gay, MD, PhD
The University of Texas MD Anderson Cancer Center

Faculty

Advisor-G1 Therapeutics (Relationship has ended)|Advisor-Abdera Therapeutics (Relationship has ended)|Advisor-AstraZeneca US|Advisor-Jazz Pharmaceuticals (Relationship has ended)|Grant or research support-AstraZeneca US|Speakers Bureau-AstraZeneca US (Relationship has ended)|Advisor-Monte Rosa (Relationship has ended)|Advisor-STCube|Advisor-Daiichi Sankyo, Inc. (Relationship has ended)|Advisor-Catalyst|Speakers Bureau-Dava Oncology

Timothy D. Gilligan, MD, FASCO, FACH
Associate Professor & Vice-Chair for Education
Cleveland Clinic Taussig Cancer Institute

Faculty

Nothing to disclose

Betty Hamilton, MD
Cleveland Clinic

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Incyte Corporation|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Angiocrine (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Maat Pharma|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Sanofi US|Membership on Advisory Committees or Review Panels, Board Membership, etc.-CSL Behring|Membership on Advisory Committees or Review Panels, Board Membership, etc.-ACI Group

Nasser H. Hanna, MD
Professor of Medicine
Indiana University

Faculty

Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Genentech, Inc.

Matthew Heeney, MD
Associate Chief - Hematology
Boston Children's Hospital

Faculty

Consulting Fee-Pharmacosmos|Consulting Fee-Keros Therapeutics

Emily Hinchcliff, MD
Assistant Professor
Northwestern Medicine

Faculty

Speakers Bureau-AbbVie Inc.

Mimi Hu, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Grant or research support-Lilly USA, LLC

Claudine Isaacs, MD, FRCPC
Professor
Georgetown

Faculty

Consulting Fee-Genentech, Inc.|Consulting Fee-Seattle Genetics, Inc.|Consulting Fee-AstraZeneca US|Consulting Fee-Novartis Pharmaceuticals Corporation|Consulting Fee-PUMA|Consulting Fee-Pfizer Inc.|Consulting Fee-ION Solutions (Relationship has ended)|Consulting Fee-Gilead Sciences, Inc.|Consulting Fee-Merck Sharp & Dohme Corp. (any division)|Honoraria-Medscape|Honoraria-MJH Holdings|Royalties or Patent Beneficiary-Wolters Kluwer|Royalties or Patent Beneficiary-McGraw Hill

Eric Jonasch, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Consulting Fee-Aveo|Grant or research support-ProFoundBio|Grant or research support-AbbVie Inc.|Grant or research support-Telix|Grant or research support-Aveo|Grant or research support-Corvus|Consulting Fee-Aravive (Relationship has ended)|Grant or research support-Arrowhead|Consulting Fee-Eisai, Inc.|Honoraria-Exelixis|Honoraria-Ipsen US|Honoraria-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis Pharmaceuticals Corporation|Honoraria-Nikang|Grant or research support-Nikang|Honoraria-Takeda (Relationship has ended)|Honoraria-DAVA

Hagop M. Kantarjian, MD
Chair, Leukemia
The University of Texas MD Anderson Cancer Center

Faculty

Grant or research support-AbbVie Inc.|Grant or research support-Amgen Inc.|Grant or research support-Pfizer Inc.|Grant or research support-Takeda|Consulting Fee-AbbVie Inc.|Consulting Fee-Amgen Inc.|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Pfizer Inc.|Consulting Fee-Takeda

Scott Kopetz, MD, PhD
Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty

Stocks or stock options, excluding diversified mutual funds-Lutris Pharmaceuticals|Advisor-Lutris Pharmaceuticals|Consulting Fee-Genentech, Inc.|Grant or research support-EMD Serono Inc.|Consulting Fee-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Novartis Pharmaceuticals Corporation|Grant or research support-Lilly USA, LLC|Consulting Fee-Boehringer Ingelheim|Grant or research support-Boehringer Ingelheim|Consulting Fee-Bayer HealthCare Pharmaceuticals, Inc.|Grant or research support-Daiichi Sankyo, Inc.|Consulting Fee-Pfizer Inc.|Grant or research support-Jazz Pharmaceuticals|Consulting Fee-Mirati Therapeutics|Consulting Fee-Flame Biosciences|Consulting Fee-Carina Biotechnology|Grant or research support-Sanofi US|Grant or research support-Guardant Health|Grant or research support-Genentech, Inc.|Grant or research support-MedImmune|Grant or research support-Amgen Inc.|Grant or research support-Lilly USA, LLC|Grant or research support-Daiichi Sankyo|Ownership-Frontier Medicines|Ownership|Consulting Fee-Frontier Medicines|Consulting Fee-Replimune|Consulting Fee-Bristol-Myers Squibb-Medarex|Consulting Fee-Amgen|Consulting Fee-Tempus|Consulting Fee-Harbinger Oncology|Consulting Fee-Zentalis|Consulting Fee-AVEO|Consulting Fee-Tachyon Therapeutics|Consulting Fee-Agenus|Consulting Fee-Revolution Medicines|Consulting Fee-Kestrel Therapeutics|Consulting Fee-Regeneron|Consulting Fee-Roche|Grant or research support-BridgeBio|Consulting Fee-Cardiff|Grant or research support-Zentalis|Grant or research support-Mirati

Alfred Lee, MD, PhD
Yale School of Medicine

Faculty

Nothing to disclose

Mark Lewis, MD
Intermountain Healthcare

Faculty

Speakers Bureau-AstraZeneca US|Speakers Bureau-Natera|Consulting Fee-Pfizer Inc. (Relationship has ended)|Consulting Fee-Astellas Scientific and Medical Affairs, Inc. (Relationship has ended)

Whitney Lewis, PharmD
Clinical Pharmacy Specialist
The University of Texas MD Anderson Cancer Center

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Johnson & Johnson|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Daiichi Sankyo, Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Eisai, Inc. (Relationship has ended)|Advisor-Bristol-Myers Squibb Company

Jennifer K. Litton, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Honoraria-UpToDate|Grant or research support-Pfizer Inc. (Relationship has ended)|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants (Relationship has ended)|Grant or research support-Zenith (Relationship has ended)|Grant or research support-AstraZeneca US (Relationship has ended)|Grant or research support-EMD Serono Inc. (Relationship has ended)|Grant or research support-GlaxoSmithKline (Relationship has ended)|Grant or research support-Genentech, Inc. (Relationship has ended)|Speakers Bureau-Clinical Care Options|Speakers Bureau-Medscape|Speakers Bureau-Physician's Education Resource|Speakers Bureau-Prime Oncology (Relationship has ended)|Speakers Bureau-Medpage|Speakers Bureau-WebMD|Royalties or Patent Beneficiary-Certis|Speakers Bureau-tumorboardtues (Relationship has ended)

Alice Ma, MD
Professor of Medicine
University of North Carolina

Faculty

Consulting Fee-Pfizer Inc. (Relationship has ended)

Claire Mach, PharmD
Clinical Pharmacy Specialist
Harris Health System

Faculty

Nothing to disclose

L. Jeffrey Medeiros, MD
Chair - Hematopathology Adm
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Stephan Moll, MD
UNC Chapel Hill

Faculty

Honoraria-Stago Diagnostics (Relationship has ended)

Alison Moskowitz, MD
Memorial Sloan Kettering Cancer Center

Faculty

Other: speaking-Takeda Pharmaceuticals (Relationship has ended)|Other: speaking-Canadian Hematology Society (Relationship has ended)|Other: speaking-Harborside Press LLC (Relationship has ended)|Other: speaking-Medscape (Relationship has ended)|Other: speaking-Tessa Therapeutics (Relationship has ended)|Other: speaking-Seagen (Relationship has ended)|Other: advisory-Affimed (Relationship has ended)|Other: advisory-Janpix Limited (Relationship has ended)|Other: advisory-Seattle Genetics (Relationship has ended)|Other: advisory-Kyowa Hakko Kirin Pharma (Relationship has ended)|Grant or research support-Incyte Corporation|Grant or research support-Merck Sharp & Dohme Corp. (any division)|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Secura-Bio

Kerry O'Brien, MD
Medical Director Blood Bank
Beth Israel Deaconess Medical Center

Faculty

Nothing to disclose

Susan O'Brien, MD
Professor of Medicine
University of California Irvine

Faculty

Consulting Fee-AbbVie Inc.|Consulting Fee-Regeneron Pharmaceuticals, Inc.|Consulting Fee-Pharmacyclics LLC|Consulting Fee-Johnson & Johnson (any division)|Consulting Fee-Janssen Biotech, Inc.|Consulting Fee-GlaxoSmithKline|Consulting Fee-Genentech, Inc.|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-AstraZeneca US

Timothy Olson, MD, PhD
Medical Director, Blood and Marrow Transplant Program
Children's Hospital of Philadelphia

Faculty

Consulting Fee-bluebird bio|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Miltenyi (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Pfizer Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Medexus (Relationship has ended)|Other: Data Safey Monitoring Board-Elixergin Therapeutics (Relationship has ended)

Antonio Omuro, MD
Stanford University

Faculty

Grant or research support-Arcus Biosciences|Consulting Fee-Ono Pharma USA, Inc (Relationship has ended)|Consulting Fee-Servier Pharmaceuticals (Relationship has ended)|Consulting Fee-Curevac AG (Relationship has ended)|Consulting Fee-Nurix (Relationship has ended)|Consulting Fee-Telix (Relationship has ended)

Brian Primeaux, PharmD
Clinical Pharmacy Specialist
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

S. Vincent Rajkumar, MD
Professor of Medicine
Mayo Clinic

Faculty

Nothing to disclose

Raajit Rampal, MD, PhD
Associate Member
MSKCC

Faculty

Consulting Fee-Incyte Corporation|Consulting Fee-Celgene Corporation|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Blueprint Medicines Corporation|Consulting Fee-AbbVie Inc.|Consulting Fee-CTI|Consulting Fee-Stemline|Consulting Fee-Galecto|Consulting Fee-Pharmaessentia|Consulting Fee-Jubilant|Consulting Fee-Constellation|Consulting Fee-Morphosys|Consulting Fee-Sierra Oncology|Consulting Fee-GSK|Consulting Fee-Protagonist|Consulting Fee-Cogent|Consulting Fee-Sumitomo Dainippon|Consulting Fee-Kartos|Consulting Fee-Servier Pharmaceuticals|Consulting Fee-Zentalis|Consulting Fee-Karyopharm Therapeutics|Grant or research support-Constellation Pharmaceuticals|Grant or research support-Ryvu|Grant or research support-Zentalis|Grant or research support-Stemline Therapeutics|Grant or research support-Incyte Corporation

A. Koneti Rao, MD
Lewis Katz School of Medicine

Faculty

Nothing to disclose

Jose Alejandro Rauh-Hain, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center

Faculty

Consulting Fee-Schlesinger Group|Consulting Fee-Guidepoint

Patrick K Reville, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Bethany T Samuelson Bannow, MD, MCR
Associate Professor
Oregon Health & Science University

Faculty

Consulting Fee-Hemabiologics (Relationship has ended)

Samuel A. Shelburne III, MD, Fellow Infectious Diseases Society of America
Professor, Infectious Diseases
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Arlene O. Siefker-Radtke, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Janssen Biotech, Inc.|Honoraria-Basilea|Honoraria-Nektar Therapeutics|Honoraria-Immunomedics|Honoraria-Loxo|Honoraria-Janssen Biotech, Inc.|Honoraria-Merck Sharp & Dohme Corp. (any division)|Honoraria-Gilead Sciences, Inc.|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Janssen Biotech, Inc.|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Honoraria-Bristol-Myers Squibb Company|Honoraria-Seattle Genetics, Inc.|Honoraria-Taiho Oncology, Inc.|Grant or research support-Basilea Pharmaceutica|Grant or research support-Nektar Therapeutics|Honoraria-G1 Therapeutics|Honoraria-AbbVie Inc.|Honoraria-Astellas Scientific and Medical Affairs, Inc.

Gerald A Soff, MD
Chief, Classical Hematology Service
University of Miami Health System/Sylvester Comprehensive Cancer Center

Faculty

Grant or research support-Amgen Inc.|Grant or research support-Janssen Biotech, Inc. (Relationship has ended)|Grant or research support-Sobi Pharmaceuticals|Grant or research support-Anthos Therapeutics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Alpine Immune Sciences, a Vertex Company|Consulting Fee-Sanofi Genzyme|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis Pharmaceuticals Corporation (Relationship has ended)

Senthil Sukumar, MD
Baylor College of Medicine

Faculty

Honoraria-Sanofi Genzyme (Relationship has ended)

William N. William Jr., MD
Medical Oncologist
Hospital BP
Brazil

Faculty

Consulting Fee-AstraZeneca US|Consulting Fee-Amgen Inc.|Consulting Fee-Bayer HealthCare Pharmaceuticals, Inc.|Consulting Fee-Boehringer Ingelheim|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Janssen Biotech, Inc.|Consulting Fee-Lilly USA, LLC|Consulting Fee-Merck Sharp & Dohme Corp. (any division)|Consulting Fee-Novartis Pharmaceuticals Corporation|Consulting Fee-Pfizer Inc.|Consulting Fee-Sanofi Genzyme|Consulting Fee-Genentech, Inc.

Robert A. Wolff, MD
Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Harry H. Yoon, MD
Associate Professor
Mayo Clinic

Faculty

Grant or research support-Bristol-Myers Squibb Company|Grant or research support-BeiGene|Grant or research support-Amgen Inc.|Grant or research support-CARsgen Therapeutics|Grant or research support-Macrogenics|Grant or research support-Merck Sharp & Dohme Corp. (any division)|Advisor-ALX Oncology|Advisor-AstraZeneca US|Advisor-BeiGene|Advisor-Bristol-Myers Squibb Company|Advisor-Macrogenics|Advisor-Merck Sharp & Dohme Corp. (any division)|Advisor-OncXerna|Advisor-Zymeworks|Advisor-Novartis Pharmaceuticals Corporation|Advisor-Astellas Scientific and Medical Affairs, Inc.|Advisor-Elevation Oncology (Relationship has ended)|Advisor-Amgen Inc.

Felisha Estelle, BBA
CE Activity Planner
The University of Texas MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Shreyaskumar Patel, MD
Professor - Sarcoma Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Consulting Fee-Daiichi Sankyo, Inc.|Consulting Fee-Deciphera

Nishin Bhadkamkar, MD
Associate Professor
The University of Texas MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Alessandra Ferrajoli, MD
Professor of Medicine
The University of Texas MD Anderson Cancer Center

Other Planning Committee Member

Membership on Advisory Committees or Review Panels, Board Membership, etc.-AbbVie Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca US (Relationship has ended)